TRACON Pharmaceuticals, Inc. (TCON)
OTCMKTS: TCON · Delayed Price · USD
0.631
+0.030 (4.99%)
Jul 22, 2024, 9:58 AM EDT - Market open
TRACON Pharmaceuticals Market Cap
TRACON Pharmaceuticals has a market cap or net worth of $1.69 million as of July 22, 2024. Its market cap has decreased by -87.00% in one year.
Market Cap
1.69M
Enterprise Value
-6.28M
1-Year Change
-87.00%
Ranking
n/a
Category
Stock Price
$0.63
Market Cap Chart
Since January 30, 2015, TRACON Pharmaceuticals's market cap has decreased from $112.60M to $1.69M, a decrease of -98.50%. That is a compound annual growth rate of -35.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2024 | 3.80M | -30.91% |
| Dec 29, 2023 | 5.50M | -83.38% |
| Dec 30, 2022 | 33.10M | -38.59% |
| Dec 31, 2021 | 53.90M | -66.33% |
| Dec 31, 2020 | 160.10M | 2,093.15% |
| Dec 31, 2019 | 7.30M | -61.17% |
| Dec 31, 2018 | 18.80M | -67.97% |
| Dec 29, 2017 | 58.70M | -8.28% |
| Dec 30, 2016 | 64.00M | -43.11% |
| Dec 31, 2015 | 112.50M | -0.09% |
| Jan 30, 2015 | 112.60M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |